Apyx Medical Stock Today

APYX Stock  USD 1.69  0.24  16.55%   

Performance

7 of 100

 
Weak
 
Strong
OK

Odds Of Distress

Less than 35

 
High
 
Low
Below Average
Apyx Medical is trading at 1.69 as of the 28th of November 2024; that is 16.55 percent increase since the beginning of the trading day. The stock's open price was 1.45. Apyx Medical has about a 35 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Apyx Medical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of December 2022 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
1st of January 1987
Category
Healthcare
Classification
Health Care
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida. Apyx Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. The company has 37.64 M outstanding shares of which 230.25 K shares are presently shorted by private and institutional investors with about 5.49 trading days to cover. More on Apyx Medical

Moving together with Apyx Stock

  0.61LH LaboratoryPairCorr

Moving against Apyx Stock

  0.51ICUI ICU MedicalPairCorr
  0.49TFX Teleflex IncorporatedPairCorr
  0.47GCTK GlucoTrackPairCorr
  0.42ZJYL JIN MEDICAL INTERNATIONALPairCorr
  0.37AHG Akso Health GroupPairCorr
  0.35FEMY FemasysPairCorr

Apyx Stock Highlights

CEO PresidentCharles II
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover1.250.6606
Way Up
Slightly volatile
Gross Profit Margin0.380.6449
Way Down
Slightly volatile
Total Current Liabilities13.4 M12.7 M
Sufficiently Up
Slightly volatile
Non Current Liabilities Total41.6 M39.6 M
Sufficiently Up
Slightly volatile
Total Assets83.2 M79.2 M
Sufficiently Up
Slightly volatile
Total Current Assets73.9 M70.4 M
Sufficiently Up
Slightly volatile
Debt Levels
Apyx Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Apyx Medical's financial leverage. It provides some insight into what part of Apyx Medical's total assets is financed by creditors.
Liquidity
Apyx Medical currently holds 38.5 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Apyx Medical has a current ratio of 4.36, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Apyx Medical's use of debt, we should always consider it together with its cash and equity.

Net Income

(17.91 Million)
Apyx Medical (APYX) is traded on NASDAQ Exchange in USA. It is located in 5115 Ulmerton Road, Clearwater, FL, United States, 33760-4004 and employs 252 people. Apyx Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 54.58 M. Apyx Medical conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 37.64 M outstanding shares of which 230.25 K shares are presently shorted by private and institutional investors with about 5.49 trading days to cover. Apyx Medical currently holds about 20.06 M in cash with (5.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58.
Check Apyx Medical Probability Of Bankruptcy
Ownership Allocation
Apyx Medical holds a total of 37.64 Million outstanding shares. 30% of Apyx Medical outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Apyx Ownership Details

Apyx Stock Institutional Holders

InstituionRecorded OnShares
Rathbone Brothers Plc2024-06-30
251.3 K
Perkins Capital Management Inc2024-09-30
217.5 K
Renaissance Technologies Corp2024-09-30
203.3 K
Bridgeway Capital Management, Llc2024-09-30
140.4 K
Kestra Advisory Services, Llc2024-06-30
124.2 K
Caption Management, Llc2024-09-30
115.5 K
State Street Corp2024-06-30
109.3 K
Dimensional Fund Advisors, Inc.2024-09-30
108.3 K
Northern Trust Corp2024-09-30
103.4 K
Archon Capital Management Llc2024-06-30
3.1 M
Royce & Associates, Lp2024-09-30
2.6 M
View Apyx Medical Diagnostics

Apyx Medical Historical Income Statement

At this time, Apyx Medical's Extraordinary Items is fairly stable compared to the past year. Reconciled Depreciation is likely to rise to about 870.7 K in 2024, whereas Total Revenue is likely to drop slightly above 26.2 M in 2024. View More Fundamentals

Apyx Stock Against Markets

Apyx Medical Corporate Executives

Elected by the shareholders, the Apyx Medical's board of directors comprises two types of representatives: Apyx Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Apyx. The board's role is to monitor Apyx Medical's management team and ensure that shareholders' interests are well served. Apyx Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Apyx Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Tara SembTreasurer CFOProfile

Already Invested in Apyx Medical?

The danger of trading Apyx Medical is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Apyx Medical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Apyx Medical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Apyx Medical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.

Additional Tools for Apyx Stock Analysis

When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.